EZ-LNP TM
Transfection Kit

Simplifying RNA delivery with our revolutionary instrument-free LNP protocol. Achieve high expression, low toxicity, and transferable results in under 1 minute.


10x
Higher Expression
50%
Less Inflammation
70%
Less pain
<1min
Protocol Time
EZ-LNP Hero Banner Image

  • Nuclear mScarlet3 mRNA delivery in caninefibroblasts
  • mRNA delivery in Human IPSC
  • mRNA Delivery in IPSC-derived cells
  • mRNA delivery in 3D hepatocyte spheroids
  • Delivery across heterogeneous iPSC spheroids
  • Z-stack confirms internal depth distribution
  • Functional ChlorON Biosensor in live organoids
  • Functional ChlorON Biosensor in Live Matrigel Dome

Revolutionary RNA Delivery Technology

Our next-generation LNP technology offers unparalleled performance with superior expression, reduced toxicity, and simplified protocols.

Complete EZ-LNP Kit Collection

SKU Name Description Add to Cart
TT300004S EZ-LNP RNA Transfection Kit - 0.3 mL A user-friendly, instrument-free LNP kit enabling effective RNA transfection in vitro and RNA delivery in vivo.
TT300004L EZ-LNP RNA Transfection Kit - 1.0 mL A user-friendly, instrument-free LNP kit enabling effective RNA transfection in vitro and RNA delivery in vivo.
TT300005 EZ-LNP Liver Delivery Kit - 1.0 mL A user-friendly, instrument-free LNP kit supporting efficient targeted delivery to liver cells for in vivo applications.
TT300006 EZ-LNP Spleen Delivery Kit - 1.0 mL A user-friendly, instrument-free LNP kit supporting efficient targeted delivery to spleen cells for in vivo applications.

Kit Includes:

EZ-LNP reagent • RNA buffer • User Manual • Technical support

EZ-LNP vs. Leading Transfection Reagents

See how our innovative LNP technology outperforms traditional transfection methods across key performance metrics.

Competitive Analysis

Feature awesomeicons/solid/star EZ-LNP™ Product L Product J
Technology Next-gen ionizable lipids with non-SORT targeting Cationic lipid transfection Polymer-based transfection
Protocol Time < 1 minute 15 minutes 30 minutes
Equipment Required None (pipette only) Incubator required Vortex mixer
Inflammation 50% Reduced Moderate High
In Vivo Compatible
Organ Targeting
RNA Types mRNA, siRNA, gRNA, all RNA types mRNA, siRNA limited mRNA optimized
Cell Viability >95% 85-90% 80-85%

* Data based on internal testing and published literature. Individual results may vary.

LNP-RNA in Seconds

Our streamlined protocol eliminates complexity and delivers consistent results in under 1 minute from start to finish.

Rapid Workflow Image

awesomeicons/solid/stopwatch

No Microfluidics Needed

Unlike traditional methods, EZ-LNP requires no specialized equipment

Case Studies & Validation

Real-world performance data demonstrating the superior efficacy and safety profile of EZ-LNP technology.

awesomeicons/regular/heart
Translatable Results
                                            Validated

Formulation: 90 µL f-Luc mRNA (130 ng/µL) + 30 µL EZ-LNP (vortex)

Dose: 3µg intramuscular injection

Result: Strong bioluminescence signal at 6h post-injection via IVIS imaging

  • awesomeicons/solid/microscope
    HEK-293T Cells (GFP Expression)
    Cell Culture Study

    Seeding: 2 x 105 cells/well (24-well plate)

    Protocol: 90 µL mRNA (130 ng/µL) + 30 µL EZ-LNP (vortex) → 5 µL/well

    Outcome: >95% GFP-positive cells (24h post-transfection)

  • awesomeicons/regular/heart
    Translatable Results
                 Validated

    Formulation: 90 µL f-Luc mRNA (130 ng/µL) + 30 µL EZ-LNP (vortex)

    Dose: 3µg intramuscular injection

    Result: Strong bioluminescence signal at 6h post-injection via IVIS imaging

awesomeicons/solid/microscope
HEK-293T Cells (GFP Expression)
Cell Culture Study

Seeding: 2 x 105 cells/well (24-well plate)

Protocol: 90 µL mRNA (130 ng/µL) + 30 µL EZ-LNP (vortex) → 5 µL/well

Outcome: >95% GFP-positive cells (24h post-transfection)

awesomeicons/regular/heart
Translatable Results
Validated

Formulation: 90 µL f-Luc mRNA (130 ng/µL) + 30 µL EZ-LNP (vortex)

Dose: 3µg intramuscular injection

Result: Strong bioluminescence signal at 6h post-injection via IVIS imaging